04/24/2024
3:57 PM | Ovid Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024
3:59 PM | Ovid Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
4:00 PM | Ovid Therapeutics (Filer)
| Form ARS | |
03/20/2024
4:22 PM | LEVIN JEREMY M (Reporting)
Ovid Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
7:20 AM | Ovid Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
7:24 AM | Ovid Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2024
4:54 PM | Duncan Barbara Gayle (Reporting)
Ovid Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/26/2024
4:56 PM | Fitzgerald Kevin Joseph (Reporting)
Ovid Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
4:57 PM | Friedman Bart (Reporting)
Ovid Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
4:58 PM | LEVIN JEREMY M (Reporting)
Ovid Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
5:00 PM | Ovid Therapeutics (Issuer)
Perone Thomas Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
5:01 PM | Ovid Therapeutics (Issuer)
Poole Robert Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
5:03 PM | Ovid Therapeutics (Issuer)
Rona Jeffrey A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
5:05 PM | Ovid Therapeutics (Issuer)
Tardio Jason (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
5:06 AM | Ovid Therapeutics (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Ovid Therapeutics (Subject)
| Form SC 13G | |
12/06/2023
4:05 PM | LEVIN JEREMY M (Reporting)
Ovid Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
4:08 PM | Ovid Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
11:15 PM | Ovid Therapeutics (Filer)
| Form EFFECT | |
11/03/2023
7:10 AM | Ovid Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
7:13 AM | Ovid Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2023
7:04 AM | Ovid Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2023
11:15 AM | Ovid Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/04/2023
8:10 AM | Ovid Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/04/2023
8:23 AM | Ovid Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/09/2023
7:54 AM | Ovid Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2023
4:29 PM | Ovid Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/05/2023
8:23 AM | Ovid Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2023
7:16 AM | Ovid Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2023
3:17 PM | Ovid Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2023
4:29 PM | Ovid Therapeutics (Filer)
| Form DEFA14A | |
